Big Gain For TC BioPharm (Holdings) plc
Wed, Apr 27, 2022 at 05:30 PM
TC BioPharm (Holdings) plc (TCBP:NASDAQ) rocketted at $1.28, a gain of 16.4%. On Tue, Apr 26, 2022, TCBP:NASDAQ hit a New 2-Week Low of $1.12. The stock got featured on our News Catalysts scanner on Tue, Apr 26, 2022 at 10:02 AM in the 'MISCELLANEOUS' category. From Wed, Apr 13, 2022, the stock recorded 50.00% Up Days and 44.44% Green Days
About TC BioPharm (Holdings) plc (TCBP:NASDAQ)
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as...
Top 10 Gainers:
- Acutus Medical Inc. (AFIB:NASDAQ), 36%
- Locafy Limited (LCFY:NASDAQ), 34.19%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 30.08%
- Studio City International Holdings Limited (MSC:NYSE), 29.73%
- Canterbury Park Holding Corporation (CPHC:NASDAQ), 22.24%
- Bon Natural Life Limited (BON:NASDAQ), 18.54%
- Elevation Oncology Inc. (ELEV:NASDAQ), 17.84%
- PAVmed Inc. (PAVM:NASDAQ), 16.51%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 16.36%
- Chindata Group Holdings Limited (CD:NASDAQ), 15.34%